MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q2
hinzugefügt 13.08.2025
Land |
 Kanada |
IPO-Jahr |
- |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ CAPITAL |
Anteile |
44.3 M |
Marktkapitalisierung |
$ 8.86 M |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
-0.58 |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
BioLineRx Ltd.
BLRX
|
$ 2.25 | 1.81 % | $ 908 M | Nasdaq Capital Market |  Israel |
 |
BioNTech SE
BNTX
|
$ 91.28 | 0.11 % | $ 27.2 B | Nasdaq Global Select Market |  Germany |
 |
MorphoSys AG
MOR
|
- | 2.43 % | $ 254 M | Nasdaq Global Select Market | Germany |
 |
Alnylam Pharmaceuticals
ALNY
|
$ 330.34 | 3.6 % | $ 43.3 B | Nasdaq Global Select Market,SPB |  USA |
 |
CollPlant Biotechnologies Ltd.
CLGN
|
$ 0.44 | -16.64 % | $ 5.04 M | Nasdaq Capital Market | Israel |
 |
I-Mab
IMAB
|
- | - | $ 866 M | Nasdaq Global Select Market |  China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
- | - | $ 40.3 B | Nasdaq Global Select Market | USA |
 |
Genfit SA
GNFT
|
- | 2.54 % | $ 160 B | Nasdaq Global Select Market |  France |
 |
Biophytis SA
BPTS
|
- | -13.47 % | $ 169 M | Nasdaq Capital Market | France |
 |
Catalyst Pharmaceuticals
CPRX
|
$ 24.98 | 1.17 % | $ 3.05 B | Nasdaq Capital Market | USA |
 |
Midatech Pharma plc
MTP
|
- | -18.52 % | $ 27.3 M | Nasdaq Global Select Market |  Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
- | -1.52 % | $ 24.7 M | Nasdaq Capital Market | USA |
 |
Corbus Pharmaceuticals Holdings
CRBP
|
$ 10.14 | -0.29 % | $ 135 M | Nasdaq Global Market | USA |
 |
Cardiff Oncology
CRDF
|
$ 1.58 | - | $ 106 M | Nasdaq Capital Market | USA |
 |
Curis
CRIS
|
$ 0.53 | -3.07 % | $ 6.98 M | Nasdaq Global Market | USA |
 |
Acorda Therapeutics
ACOR
|
- | -24.86 % | $ 820 K | Nasdaq Global Select Market | USA |
 |
Crinetics Pharmaceuticals
CRNX
|
$ 37.7 | 1.26 % | $ 3.55 B | Nasdaq Global Select Market | USA |
 |
CRISPR Therapeutics AG
CRSP
|
$ 49.15 | -0.73 % | $ 4.42 B | Nasdaq Global Market,SPB |  Schweiz |
 |
Adverum Biotechnologies
ADVM
|
- | - | $ 86.2 M | Nasdaq Global Market | USA |
 |
Advaxis
ADXS
|
- | -9.65 % | $ 45.9 M | Nasdaq Capital Market | USA |
 |
Anavex Life Sciences Corp.
AVXL
|
$ 2.96 | -1.0 % | $ 252 M | Nasdaq Capital Market | USA |
 |
Applied Molecular Transport
AMTI
|
- | - | $ 10.1 M | Nasdaq Global Select Market,SPB | USA |
 |
Aeterna Zentaris
AEZS
|
- | 5.93 % | $ 314 M | Nasdaq Capital Market | Canada |
 |
AgeX Therapeutics
AGE
|
- | -10.17 % | $ 12.2 K | NYSE American | USA |
 |
AIkido Pharma
AIKI
|
- | 1.93 % | $ 17.4 M | Nasdaq Capital Market | USA |
 |
Aeglea BioTherapeutics
AGLE
|
- | - | $ 1.01 B | Nasdaq Global Market | USA |
 |
CytomX Therapeutics
CTMX
|
$ 4.4 | -3.51 % | $ 607 M | Nasdaq Global Select Market | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
- | - | $ 26.5 M | Nasdaq Global Select Market | USA |
 |
Akero Therapeutics
AKRO
|
- | - | $ 3.67 B | Nasdaq Global Select Market,SPB | USA |
 |
Akouos
AKUS
|
- | 0.23 % | $ 488 M | Nasdaq Global Select Market | USA |
 |
Институт стволовых клеток человека
ISKJ
|
- | - | - | MOEX |  Russia |
 |
Citius Pharmaceuticals
CTXR
|
$ 0.86 | 0.67 % | $ 5.79 M | Nasdaq Capital Market | USA |
 |
Cue Biopharma
CUE
|
$ 0.18 | -1.61 % | $ 17.1 M | Nasdaq Capital Market,SPB | USA |
 |
Allena Pharmaceuticals
ALNA
|
- | 3.16 % | $ 1.9 M | Nasdaq Global Select Market | USA |
 |
Alpine Immune Sciences
ALPN
|
- | - | $ 2.17 B | Nasdaq Global Market | USA |
 |
Aileron Therapeutics
ALRN
|
- | 10.36 % | $ 9.8 M | Nasdaq Global Select Market | USA |
 |
Aquestive Therapeutics
AQST
|
$ 4.09 | -0.97 % | $ 437 M | Nasdaq Global Market | USA |
 |
Cyclerion Therapeutics
CYCN
|
$ 4.15 | -32.52 % | $ 10.4 M | Nasdaq Global Select Market | USA |
 |
Daré Bioscience
DARE
|
$ 1.81 | 4.02 % | $ 20.2 M | Nasdaq Capital Market | USA |
 |
DBV Technologies S.A.
DBVT
|
$ 20.36 | -3.32 % | $ 2.84 B | Nasdaq Global Select Market | France |
 |
Aravive
ARAV
|
- | -13.39 % | $ 1.45 M | Nasdaq Global Select Market | USA |
 |
Arcturus Therapeutics Holdings
ARCT
|
$ 8.22 | 2.37 % | $ 225 M | Nasdaq Global Market,SPB | Israel |
 |
Aptose Biosciences
APTO
|
- | -45.71 % | $ 1.2 M | Nasdaq Capital Market | Canada |
 |
Aptinyx
APTX
|
- | -39.0 % | $ 4.57 M | Nasdaq Global Select Market | USA |
 |
Denali Therapeutics
DNLI
|
$ 19.38 | -6.15 % | $ 3.19 B | Nasdaq Global Select Market,SPB | USA |
 |
Dyadic International
DYAI
|
$ 0.87 | -2.8 % | $ 31.5 M | Nasdaq Capital Market | USA |
 |
CureVac N.V.
CVAC
|
- | - | $ 867 M | Nasdaq Global Market | Germany |
 |
AstraZeneca PLC
AZN
|
- | - | $ 96.9 B | Nasdaq Global Select Market | Britain |
 |
Celldex Therapeutics
CLDX
|
$ 31.37 | 1.0 % | $ 2.08 B | Nasdaq Global Select Market | USA |
 |
Avenue Therapeutics
ATXI
|
- | -52.27 % | $ 4.45 M | Nasdaq Global Select Market | USA |